The Cooper Companies, Inc. is a rapidly growing
specialty healthcare company serving the vision care and women's healthcare
markets around the world with high quality products and services.
CooperVision markets a broad range of contact lenses, concentrating
on high-growth value-added market segments.
CooperSurgical offers diagnostic products as well as surgical instruments
and accessories used primarily by gynecologists and obstetricians.
Selected Financial Information for Five Years
THE COOPER COMPANIES, INC. (NYSE:COO)
(In thousands except per share data) |
2 0 0 0
|
1 9 9 9
|
1 9 9 8
|
1 9 9 7
|
1 9 9 6
|
|
Per Share Information:
|
|
|
|
|
|
Income from continuing operations* |
$
|
2.03
|
$
|
1.54
|
$
|
0.91
|
$
|
0.77
|
$
|
0.57
|
Net income as reported |
$
|
2.00
|
$
|
1.75
|
$
|
2.61
|
$
|
2.39
|
$
|
1.41
|
Dividends |
$
|
0.08
|
$
|
0.04
|
N/A
|
N/A
|
N/A
|
Cash flow** |
$
|
3.51
|
$
|
2.82
|
$
|
1.93
|
$
|
1.50
|
$
|
1.13
|
|
|
|
|
|
|
|
|
Diluted average shares |
$
|
14,510
|
$
|
14,312
|
$
|
15,269
|
$
|
13,120
|
$
|
11,794
|
Stock price - high |
$
|
38.81
|
$
|
31.88
|
$
|
51.69
|
$
|
41.13
|
$
|
15.13
|
Stock price - low |
$
|
24.63
|
$
|
11.75
|
$
|
14.00
|
$
|
14.00
|
$
|
5.63
|
|
|
|
|
|
|
|
|
Sales |
$
|
197,317
|
$
|
165,328
|
$
|
147,192
|
$
|
88,769
|
$
|
66,118
|
Gross profit |
$
|
129,217
|
$
|
106,319
|
$
|
91,428
|
$
|
61,444
|
$
|
46,207
|
Operating income |
$
|
46,869
|
$
|
38,811
|
$
|
29,700
|
$
|
19,803
|
$
|
14,270
|
Operating income/sales |
24%
|
23%
|
20%
|
22%
|
22%
|
Interest expense |
$
|
4,744
|
$
|
6,330
|
$
|
6,253
|
$
|
3,174
|
$
|
3,421
|
Provision for (benefit of ) income taxes |
$
|
12,727
|
$
|
10,711
|
$
|
(34,723)
|
$
|
(26,735)
|
$
|
(4,438)
|
|
|
|
|
|
|
|
|
Working capital |
$
|
47,410
|
$
|
58,565
|
$
|
69,376
|
$
|
71,456
|
$
|
32,394
|
Property, plant and equipment, net |
$
|
47,933
|
$
|
40,319
|
$
|
34,234
|
$
|
7,634
|
$
|
4,650
|
Total assets |
$
|
322,565
|
$
|
285,873
|
$
|
296,041
|
$
|
170,624
|
$
|
84,230
|
Total debt |
$
|
48,351
|
$
|
61,955
|
$
|
90,247
|
$
|
9,563
|
$
|
38,089
|
|
|
|
|
|
|
|
|
Capital expenditures |
$
|
14,665
|
$
|
10,121
|
$
|
19,573
|
$
|
7,735
|
$
|
3,182
|
Depreciation and amortization |
$
|
8,734
|
$
|
8,440
|
$
|
8,416
|
$
|
4,267
|
$
|
3,352
|
|
* 1996, 1997 and 1998 are pro forma, assuming a 40
percent tax rate
** Pretax income from continuing operations plus depreciation and amortization
|